Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Yale University
M.D. Anderson Cancer Center
Mayo Clinic
University of Alabama at Birmingham
H. Lee Moffitt Cancer Center and Research Institute